Skip to main content

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

LKFT holding history

Lakefront Biotherapeutics NV in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LKFT overviewAll 13F holders of LKFTFull Q2 2026 holdings

Shares (Q2 2026)
407,800
Value
$12.2M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LKFT by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026407,800$12.2M<0.1%+92,400+29.3%AddedHolders
Q1 2026315,400$9.46M<0.1%+4,800+1.5%AddedHolders
Q4 2025310,600$10.2M<0.1%−45,600−12.8%ReducedHolders
Q3 2025356,200$12.3M<0.1%−108,500−23.3%ReducedHolders
Q2 2025464,700$13.0M<0.1%+133,900+40.5%AddedHolders
Q1 2025330,800$8.31M<0.1%+34,700+11.7%AddedHolders
Q4 2024296,100$8.14M<0.1%+4,421+1.5%AddedHolders
Q3 2024291,679$8.40M<0.1%+20,879+7.7%AddedHolders
Q2 2024270,800$6.71M<0.1%+4,300+1.6%AddedHolders
Q1 2024266,500$8.58M<0.1%+3,300+1.3%AddedHolders
Q4 2023263,200$10.7M<0.1%−18,600−6.6%ReducedHolders
Q3 2023281,800$9.74M<0.1%−26,100−8.5%ReducedHolders
Q2 2023307,900$12.5M<0.1%−50,500−14.1%ReducedHolders
Q1 2023358,400$13.8M<0.1%+22,020+6.5%AddedHolders
Q4 2022336,380$14.9M<0.1%+37,780+12.7%AddedHolders
Q3 2022298,600$12.7M<0.1%+50,300+20.3%AddedHolders
Q2 2022248,300$13.9M<0.1%+163,800+193.8%AddedHolders
Q1 202284,500$5.24M<0.1%+27,900+49.3%AddedHolders
Q4 202156,600$3.12M<0.1%+5,700+11.2%AddedHolders
Q3 202150,900$2.68M<0.1%+40,700+399.0%AddedHolders
Q2 202110,200$703.0K<0.1%−500−4.7%ReducedHolders
Q1 202110,700$825.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.